Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Explore the essentials of the W-8BEN form for non-US residents with ETF dividends, including who qualifies and how it reduces tax withholding.
14,027 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Three AI ETFs—CHAT, IGPT, and WISE—have consistently surfaced as thoughtful ways to own the generative AI theme, each...
A pipeline-focused ETF is drawing retirees with its steady monthly payouts, delivering roughly 7.8% annual yield and ...
Bitcoin slides toward $60,000 raise fresh concerns for BLOK, the blockchain-focused ETF. This report explains potenti...
Through the first three months of 2026, the stock market diverged: the S&P 500 fell, while smaller firms outperformed...
The oil ETF that doubled in 2026 is navigating a renewed tug of war between supply shocks and capacity restoration. H...
A weekly ETF flow snapshot shows large outflows from U.S. spot Bitcoin and Ethereum ETFs even as XRP and HYPE attract...
Institutions are back in force for Bitcoin, led by US Bitcoin ETFs and MicroStrategy buying. Flows total about $1.25B...
Trifecta of forecasts from the leading claude price prediction tie Bitcoin, Solana and XRP to live market catalysts. ...
Zcash (ZEC) shows a renewed bullish setup as a 12-hour TD Sequential buy signal appears, with traders eyeing a potent...
South Korea revealed a sweeping $590 billion plan to boost memory chips and AI hardware, triggering gains in semicond...
When markets swing wildly, stability becomes a valuable asset. This article spotlights two defensive ETFs that priori...